Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - Euronext Paris - Matif - FR0000063935 - Common Stock - Currency: EUR

7.91  +0.37 (+4.91%)

Fundamental Rating

3

Overall BON gets a fundamental rating of 3 out of 10. We evaluated BON against 55 industry peers in the Food Products industry. Both the profitability and financial health of BON have multiple concerns. BON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BON has reported negative net income.
In the past year BON had a positive cash flow from operations.
BON had positive earnings in 4 of the past 5 years.
BON had a positive operating cash flow in 4 of the past 5 years.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of BON (-6.06%) is worse than 82.14% of its industry peers.
The Return On Equity of BON (-21.14%) is worse than 82.14% of its industry peers.
With a Return On Invested Capital value of 5.16%, BON perfoms like the industry average, outperforming 44.64% of the companies in the same industry.
BON had an Average Return On Invested Capital over the past 3 years of 3.87%. This is below the industry average of 7.02%.
The last Return On Invested Capital (5.16%) for BON is above the 3 year average (3.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

BON has a Operating Margin (3.73%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BON has declined.
BON's Gross Margin of 28.41% is on the low side compared to the rest of the industry. BON is outperformed by 66.07% of its industry peers.
BON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BON is still creating some value.
BON has about the same amout of shares outstanding than it did 1 year ago.
BON has about the same amout of shares outstanding than it did 5 years ago.
BON has a worse debt/assets ratio than last year.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.91 indicates that BON is not a great score, but indicates only limited risk for bankruptcy at the moment.
BON has a Altman-Z score of 1.91. This is comparable to the rest of the industry: BON outperforms 41.07% of its industry peers.
BON has a Debt/Equity ratio of 0.88. This is a neutral value indicating BON is somewhat dependend on debt financing.
BON's Debt to Equity ratio of 0.88 is on the low side compared to the rest of the industry. BON is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC1.01
WACC5.11%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.33 indicates that BON should not have too much problems paying its short term obligations.
With a Current ratio value of 1.33, BON perfoms like the industry average, outperforming 48.21% of the companies in the same industry.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
With a Quick ratio value of 0.43, BON is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -8526.77% in the last year.
Looking at the last year, BON shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
Measured over the past years, BON shows a decrease in Revenue. The Revenue has been decreasing by -3.11% on average per year.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

Based on estimates for the next years, BON will show a very strong growth in Earnings Per Share. The EPS will grow by 23.09% on average per year.
The Revenue is expected to grow by 2.07% on average over the next years.
EPS Next Y1.9%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
EPS Next 5YN/A
Revenue Next Year-2.72%
Revenue Next 2Y-0.52%
Revenue Next 3Y0.48%
Revenue Next 5Y2.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BON. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 6.14 indicates a rather cheap valuation of BON.
85.71% of the companies in the same industry are more expensive than BON, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.72. BON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.14
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BON indicates a rather cheap valuation: BON is cheaper than 94.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.15
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BON's earnings are expected to grow with 23.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.28%
EPS Next 3Y23.09%

More info and screens

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.61%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.39, BON has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, BON has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.61%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

BON has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.39%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

More info and screens

BONDUELLE SCA

EPA:BON (3/21/2025, 7:00:00 PM)

7.91

+0.37 (+4.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-05 2025-03-05
Earnings (Next)05-06 2025-05-06
Inst Owners6.51%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap258.10M
Analysts78
Price Target8.93 (12.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.61%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.14
P/S 0.11
P/FCF N/A
P/OCF 3.76
P/B 0.42
P/tB 0.8
EV/EBITDA 3.15
EPS(TTM)-4.03
EYN/A
EPS(NY)1.29
Fwd EY16.29%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY26.62%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.91
F-Score4
WACC5.11%
ROIC/WACC1.01
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y1.9%
EPS Next 2Y21.28%
EPS Next 3Y23.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-2.72%
Revenue Next 2Y-0.52%
Revenue Next 3Y0.48%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1267.64%
EBIT Next 3Y149.65%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A